CASE REPORTS
JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

A rare case of quadruple valve infective endocarditis of normal native valves - the advantage of TEE.

Quadruple valve infective endocarditis of apparently normal native valves is a relatively uncommon condition, reported particularly in the setting of intravenous drug use, structural heart disease and immunocompromised state, but its occurrence outside these settings is rare. Multiple valve endocarditis is caused by Staphylococcus aureus in the majority of cases. Although Enterococcus faecalis is a common cause of bacterial infective endocarditis overall, it is rarely reported to cause multiple valve involvement. The present case is one such rare report of a patient who had quadruple valve endocarditis of normal native valves, caused by E. faecalis. Compared to single valve endocarditis, multiple valve disease is associated more frequently with heart failure, perivalvular complications and need for heart surgery; hence, early recognition of the extent of disease and number of valves involved is crucial, as this in turn influences the management, risk of complications and outcomes. Transthoracic echocardiography is a widely used first-line tool in the imaging of infective endocarditis, but transesophageal echocardiography, which is more sensitive, should be used more frequently to assess the extent of involvement. Extensive valvular involvement alone does not preclude medical management, and surgical management should be considered only in those who do not respond to antimicrobials or in the case of hemodynamic compromise or mechanical complications.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app